Jun-03-18
A responsive DBS implant device for Parkinson’s disease can adjust its signaling based on feedback from the brain.
Developed as part of a study by the National Institute of Health, the DBS (deep brain stimulating) device is the first of its kind able to fine-tune itself to adapt to the needs of the patient. While simulation of the basal ganglia has been shown to be helpful in treating Parkinson’s patients, the technology can cause unwanted side effects and require reprogramming. In contrast, the new device is equipped with an additional electronic circuit able to sense and adapt to variations in brain activity and improve therapy in a significant way, while also consuming less power.
Add Your Comment